Large-scale testing (Phase 3)Study completedNCT01165008What this trial is testingAnakinra in MyositisWho this might be right forPolymyositisDermatomyositisInclusion Body Myositis Karolinska Institutet
Early research (Phase 1)Ended earlyNCT06524687What this trial is testingImvotamab in Active, Refractory Idiopathic Inflammatory MyopathiesWho this might be right forIdiopathic Inflammatory MyopathiesInflammatory Myopathies IGM Biosciences, Inc. 2
Early research (Phase 1)Enrolling By InvitationNCT07038447What this trial is testingKITE-363 in Participants With Refractory Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more Kite, A Gilead Company 52
Very early researchLooking for participantsNCT07174843What this trial is testingAn Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune DiseasesWho this might be right forIdiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE) Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Ended earlyNCT00278564What this trial is testingStem Cell Transplantation in Idiopathic Inflammatory Myopathy DiseasesWho this might be right forMYOPATHY Northwestern University 7
Early research (Phase 1)Looking for participantsNCT07361094What this trial is testingAutologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune DiseasesWho this might be right forRelapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more Beijing Boren Hospital 12
Early research (Phase 1)Looking for participantsNCT06941129What this trial is testingCAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusSystemic Sclerosis (SSc)Inflammatory Myopathy+3 more Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableLooking for participantsNCT06373081What this trial is testingAnti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseWho this might be right forSystemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more Shanghai Changzheng Hospital 6
Early research (Phase 1)Looking for participantsNCT06686524What this trial is testingClinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)Who this might be right forDermatomyositis, JuvenileDermatomyositis Chongqing Precision Biotech Co., Ltd 18
Not applicableLooking for participantsNCT06379646What this trial is testingAn Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseWho this might be right forSystemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Early research (Phase 1)Looking for participantsNCT06978647What this trial is testingA Clinical Study of YTS109 Cell in R/R Autoimmune DiseasesWho this might be right forSystemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Early research (Phase 1)Not Yet RecruitingNCT07123519What this trial is testingA Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune DiseasesWho this might be right forSystemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Very early researchNot Yet RecruitingNCT07410377What this trial is testingUCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusInflammatory Myopathy The Affiliated Hospital of Xuzhou Medical University 15
Testing effectiveness (Phase 2)WithdrawnNCT07012057What this trial is testingStudy of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile DermatomyositisWho this might be right forMyositisDermatomyositis National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Large-scale testing (Phase 3)Study completedNCT02347891What this trial is testingBelimumab in Idiopathic Inflammatory MyositisWho this might be right forMyositis Northwell Health 17
Early research (Phase 1)Not Yet RecruitingNCT07236801What this trial is testingExploratory Clinical Study on YTS109 Cell Therapy for Autoimmune DiseasesWho this might be right forSystemic Lupus Erythematosus (SLE)Systemic SclerosisSjogren's Syndrome (SS)+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT07115745What this trial is testingHealthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesWho this might be right forRefractory Autoimmune Diseases Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Early research (Phase 1)Study completedNCT03002649What this trial is testingStudy of Tofacitinib in Refractory DermatomyositisWho this might be right forDermatomyositis Johns Hopkins University 10
Early research (Phase 1)Looking for participantsNCT05869955What this trial is testingCC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Who this might be right forSystemic Lupus ErythematosusIdiopathic Inflammatory MyopathySystemic Sclerosis+1 more Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 270
Early research (Phase 1)Looking for participantsNCT07085676What this trial is testingPhase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune DiseasesWho this might be right forSystemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)+1 more Polina Stepensky 60